Alan Dunton

Alan Dunton

Direttore/Membro del Consiglio presso CORMEDIX INC.

Patrimonio netto: 595 501 $ in data 31/05/2026

71 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Dr. Alan W.
Dunton
, MD, is an Independent Non-Executive Director at Recce Pharmaceuticals Ltd., an Independent Director at CorMedix, Inc., an Independent Director at Palatin Technologies, Inc. and an Independent Director at Oragenics, Inc. He is on the Board of Directors at Recce Pharmaceuticals Ltd., CorMedix, Inc., Cytogel Pharma LLC, Palatin Technologies, Inc., Oragenics, Inc. and ActivBiotics, Inc. Dr. Dunton was previously employed as an Independent Non-Executive Director by Regeneus Ltd., a SVP-Regulatory Affairs, Research & Development by Purdue Pharma LP, a Non-Executive Director by Bionomics Ltd., a Chief Medical Officer by Derma Sciences, Inc., a Non-Executive Chairman by EpiCept Corp., a Chief Medical Officer by Marina Biotech, Inc., a Managing Director by Panacos Pharmaceuticals, Inc., an Independent Director by Targacept, Inc., a Principal Owner by Danerius LLC, a President & Chief Executive Officer by Metaphore Pharmaceuticals, Inc., a President, Chief Operating Officer & Director by Emisphere Technologies, Inc., a President & Managing Director by The Janssen Research Foundation, a Senior Executive by Johnson & Johnson, a Vice President-Clinical Research & Development by Syntex Corp., a Vice President-Clinical Research & Development by Ciba-Geigy Corp., a Vice President-Clinical Research & Development by Hoffmann-La Roche, Inc., a Chairman by Janssen-Cilag International NV, He received his undergraduate degree from State University of New York at Buffalo and a doctorate degree from New York University School of Medicine.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
13/04/2026 40.250 ( 0,05% ) 339 710 $ 31/05/2026
09/12/2025 14.081 ( 0,79% ) 197 416 $ 31/05/2026
30/06/2025 146.288 ( 0,05% ) 57 889 $ 31/05/2026
30/04/2026 802 ( 0,02% ) 486 $ 31/05/2026

Posizioni attive di Alan Dunton

SocietàPosizioneInizio
CORMEDIX INC. Direttore/Membro del Consiglio 01/03/2019
ORAGENICS, INC. Direttore/Membro del Consiglio 01/04/2011
PALATIN TECHNOLOGIES, INC. Direttore/Membro del Consiglio 22/06/2011
RECCE PHARMACEUTICALS LTD Direttore/Membro del Consiglio 14/07/2020
Direttore/Membro del Consiglio 01/10/2018
Direttore/Membro del Consiglio 01/01/2007

Precedenti posizioni note di Alan Dunton

SocietàPosizioneFine
REGENEUS LTD Direttore/Membro del Consiglio 25/02/2021
Direttore Tecnico/Scientifico/R&S 01/03/2018
ADHERA THERAPEUTICS, INC. Direttore Tecnico/Scientifico/R&S 21/02/2017
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Alan Dunton

Formazione di Alan Dunton

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

71

Relazioni di 1° grado

34

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private34

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Retail Trade

Consumer Services

Health Technology

Health Technology

Health Technology

The Janssen Research Foundation

R.W. Johnson Pharmaceutical Research Institute

Danerius LLC

Commercial Services

Johnson & Johnson Pharmaceutical Group

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Alan Dunton
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA